Cargando...
Treatment of non-metastatic castration-resistant prostate cancer: focus on apalutamide
Androgen deprivation therapy (ADT) is an important component of systemic therapy in advanced prostate cancer; however, resistance to ADT is inevitable. Three large studies demonstrated the efficacy of novel androgen receptor (AR)-targeted therapies in prolonging metastasis-free survival and time to...
Gardado en:
| Publicado en: | Cancer Manag Res |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Dove
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6682169/ https://ncbi.nlm.nih.gov/pubmed/31534371 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S165706 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|